329 related articles for article (PubMed ID: 28532352)
1. Understanding Glaucomatous Optic Neuropathy: The Synergy Between Clinical Observation and Investigation.
Quigley HA
Annu Rev Vis Sci; 2016 Oct; 2():235-254. PubMed ID: 28532352
[TBL] [Abstract][Full Text] [Related]
2. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
Yamamoto T
Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
[TBL] [Abstract][Full Text] [Related]
3. Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy.
Osborne NN; Chidlow G; Wood J; Casson R
Eur J Ophthalmol; 2003 Apr; 13 Suppl 3():S19-26. PubMed ID: 12749673
[TBL] [Abstract][Full Text] [Related]
4. Should we treat the brain in glaucoma?
Gupta N; Yücel YH
Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036
[TBL] [Abstract][Full Text] [Related]
5. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy.
Levin LA
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S98-101. PubMed ID: 10416753
[TBL] [Abstract][Full Text] [Related]
6. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
[TBL] [Abstract][Full Text] [Related]
7. Current understanding of neuroprotection in glaucoma.
Wein FB; Levin LA
Curr Opin Ophthalmol; 2002 Apr; 13(2):61-7. PubMed ID: 11880717
[TBL] [Abstract][Full Text] [Related]
8. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
Rokicki W; Dorecka M; Romaniuk W
Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
[TBL] [Abstract][Full Text] [Related]
9. Optic nerve and neuroprotection strategies.
Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
[TBL] [Abstract][Full Text] [Related]
10. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].
Rokicki W; Dorecka M; Romaniuk W
Klin Oczna; 2007; 109(7-9):353-5. PubMed ID: 18260297
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.
Hare WA; WoldeMussie E; Weinreb RN; Ton H; Ruiz G; Wijono M; Feldmann B; Zangwill L; Wheeler L
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2640-51. PubMed ID: 15277487
[TBL] [Abstract][Full Text] [Related]
12. The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications.
Yang H; Reynaud J; Lockwood H; Williams G; Hardin C; Reyes L; Stowell C; Gardiner SK; Burgoyne CF
Prog Retin Eye Res; 2017 Jul; 59():1-52. PubMed ID: 28300644
[TBL] [Abstract][Full Text] [Related]
13. The morphological difference between glaucoma and other optic neuropathies.
Burgoyne C
J Neuroophthalmol; 2015 Sep; 35 Suppl 1(0 1):S8-S21. PubMed ID: 26274837
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma.
Neufeld AH
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S129-35. PubMed ID: 10416755
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
Attarzadeh A; Hosseini H; Nowroozizadeh S
Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
[TBL] [Abstract][Full Text] [Related]
17. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage.
Morgan JE
Eye (Lond); 2000 Jun; 14 ( Pt 3B)():437-44. PubMed ID: 11026971
[TBL] [Abstract][Full Text] [Related]
18. Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma.
Quigley HA; Pitha IF; Welsbie DS; Nguyen C; Steinhart MR; Nguyen TD; Pease ME; Oglesby EN; Berlinicke CA; Mitchell KL; Kim J; Jefferys JJ; Kimball EC
PLoS One; 2015; 10(10):e0141137. PubMed ID: 26505191
[TBL] [Abstract][Full Text] [Related]
19. Glaucoma as a neurodegenerative disease.
Gupta N; Yücel YH
Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
[TBL] [Abstract][Full Text] [Related]
20. [Glaucoma--neurodegenerative disease].
Tataru LC; Bogdănici CM
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1120-5. PubMed ID: 20191885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
